This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Two basic causal mechanisms—a defect in catecholamine metabolism and a concentration of sodium in vascular smooth muscle—have emerged from "the welter of research" in essential hypertension, in the opinion of Dr. Milton Mendlowitz of the Department of Medicine at Mount Sinai Hospital in New York.
Speaking at the American College of Chest Physicians meeting in Atlantic City, Mendlowitz offered the following evidence that a basic abnornality of catecholamine metabolism exists in essential hypertension:
"Most successful therapy in essential hypertension influences the catecholamine complex in one way or another, resulting in a decrease in free l-norepinephrine (NE) available for vasoconstriction. The drugs may inhibit release of NE, deplete stores, or compete with effector sites, and are usually more effective in hypertensive than in normotensive states.
"Second, the systemic blood vessels of patients with hypertension and even of their offspring are more reactive to NE as well as to other vasoactive
ESSENTIAL HypertensionTwo basic causal mechanisms—the defect in catecholamine metabolism and concentration of sodium in vascular smooth muscle. JAMA. 1963;185(5):34–35. doi:10.1001/jama.1963.03060050010006
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: